Navigation Links
Gene study offers clues on memory puzzle
Date:7/8/2011

Scientists have shed light on why it is easier to learn about things related to what we already know than it is to learn about unfamiliar things, according to a new study.

The team says this is a paradox, as very different things are arguably more novel, yet adding to what we already know is so much easier.

Researchers at the Universities of Edinburgh and Tokyo have found that building on existing knowledge activates a key set of genes in the brain.

These 'plasticity' genes do not respond so well to subjects about which we know very little, making it harder for us to form new memories about unfamiliar topics.

The team says this could help us understand how professionals acquire their knowledge gradually over time and may inform new educational strategies to boost learning.

The study, conducted in partnership with Mitsubishi Tanabe Pharmaceutical Company, was funded by the Medical Research Council.

The findings have been published in the journal Science.

Professor Richard Morris of the University of Edinburgh, who led the study, said: "This curious effect is seen in a specific part of the cortex whose functions are still poorly understood so there is still much work to be done. But a combination of biomedical and human brain imaging work has this as a key aim for future research. We also plan to look at how professional knowledge is gradually acquired and organised in the brain".


'/>"/>

Contact: Anna Borthwick
anna.borthwick@ed.ac.uk
44-131-650-4400
University of Edinburgh
Source:Eurekalert

Page: 1

Related medicine news :

1. Men Who Smoke at Lower Risk of Joint Replacement: Study
2. Religious Identity Remains Constant in Teen Years: Study
3. Study: Hypoallergenic dogs not less allergic than other dogs
4. MU study identifies protective factors that help women recover from childhood violence
5. Study Questions Chiropractics Impact on Back Pain
6. Medicaid Coverage Substantially Improves Access to Care: Study
7. Previous cancer history increases chances of clotting disorders after knee surgery, study suggests
8. Endosonography followed by surgical staging improves quality of life, according to ASTER study
9. Study Finds Heart Failure Drug Ineffective
10. New study: Women less likely than men to fake soccer injuries
11. Long Commutes for Pilots May Hamper Flying Performance: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... thought leadership , media relations, content marketing, social media management, corporate communications, SEO ... already in the state and in nearby New Hampshire, Massachusetts and Canada, Rosica ...
(Date:2/23/2017)... ... February 23, 2017 , ... Pink Pig Publishing LLC announces ... and explore the world from different perspectives. By providing a place for people ... understanding, increase empathy, and find greater happiness. , "Our approach to structuring ...
(Date:2/23/2017)... ... 23, 2017 , ... The Center for Autism and Related ... Autism Research and Treatment (RI-CART) and Cinemaworld to present Sensory Friendly Films. The ... see films in an environment that accommodates their unique needs. , Launched in ...
(Date:2/23/2017)... ... February 23, 2017 , ... Curemark, LLC announced today that ... of CM-AT in children aged 3-8 with Autism, is now enrolling at three new ... children across the United States. , “There are currently no approved drugs that ...
(Date:2/22/2017)... York (PRWEB) , ... February 22, 2017 , ... ... entrance and lobby of a new healthcare contact center in Georgia, PENETRON Specialty ... One of the nation’s largest healthcare systems recently invested $51 million to purchase ...
Breaking Medicine News(10 mins):
(Date:2/23/2017)... Feb. 23, 2017   SeraCare Life Sciences ... in vitro diagnostics manufacturers and clinical laboratories, is ... Implementation of NGS-Based Tests" to be hosted by ... at 11am Eastern Standard Time (US). ... the need for improved performance and global standardization ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... a clinical-stage oncology drug development company, announces that ... and Drug Administration (FDA) authorizing the initiation a ... therapeutic treatment for pancreatic cancer. MVT-1075 ( 177 ... radioimmunotherapy (RIT). MabVax plans to initiate the phase ...
(Date:2/23/2017)... This report analyzes analyzes the worldwide markets for Wound Debridement Products ... the US, Canada , Japan ... , Latin America , and Rest ... period 2015 through 2022. Also, a six-year historic analysis is ... from primary and secondary research. Company profiles are primarily based ...
Breaking Medicine Technology: